| Chen, Hui |
NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients |
|
|
| Recruiting | 4 | 5000 | RoW | Peginterferon Alfa-2B, Nucleoside Analogs | Third Affiliated Hospital, Sun Yat-Sen University | Hepatitis B, Chronic | 12/26 | 11/29 | | |
NCT04683406: A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A |
|
|
| Completed | 3 | 750 | RoW | ZSP1273 600 mg, Placebo to Oseltamivir, Oseltamivir(oral), Placebo to ZSP1273 | Guangdong Raynovent Biotech Co., Ltd | Influenza A | 04/23 | 05/23 | | |
| Recruiting | 3 | 1300 | Europe, Canada, Japan, US, RoW | TAK-279 | Takeda | Plaque Psoriasis | 05/26 | 05/26 | | |
TAK-279-3002, NCT06108544: A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period |
|
|
| Active, not recruiting | 3 | 1108 | Europe, Canada, US, RoW | TAK-279, Placebo, Apremilast | Takeda | Plaque Psoriasis | 12/24 | 11/25 | | |
CYCLONE 3, NCT05288166: A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) |
|
|
| Active, not recruiting | 3 | 900 | Europe, Canada, Japan, US, RoW | Abemaciclib, LY2835219, Abiraterone, Prednisone or Prednisolone, Placebo for Abemaciclib | Eli Lilly and Company | Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms, Physiological Effects of Drugs, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Androgens, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Abiraterone Acetate, Steroid Synthesis Inhibitors, Cytochrome P-450, Enzyme Inhibitors, Prednisone, Prednisolone, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6 | 02/24 | 10/27 | | |
NCT04691804 / 2020-006063-28: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer |
|
|
| Active, not recruiting | 3 | 496 | Europe, US, RoW | Fuzuloparib , Abiraterone acetate and Prednisone, SHR3162, Fuzuloparib Placebo， Abiraterone acetate and Prednisone | Jiangsu HengRui Medicine Co., Ltd. | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | 12/26 | 12/26 | | |
RAMP 301, NCT06072781: A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer |
|
|
| Recruiting | 3 | 270 | Europe, Canada, US, RoW | avutometinib, avutometinib (VS-6766), Defactinib, defactinib (VS-6063), Pegylated liposomal doxorubicin, Caelyx, Doxil, Lipodox, Paclitaxel, Nov-Onxol, Onxol, Navaplus, Taxol, Letrozole, Femara, Anastrozole, Arimidex | Verastem, Inc., GOG Foundation, European Network of Gynaecological Oncological Trial Groups (ENGOT), Australia New Zealand Gynaecological Oncology Group | Low Grade Serous Ovarian Cancer | 10/28 | 02/31 | | |
NCT01024530: Phase II/III Trial of Hepatocellular Carcinoma Patients Treated by ex Vivo Expanded Autologous Immune Killer Cells as the Adjunct Therapy |
|
|
| Recruiting | 2/3 | 60 | RoW | immune killer cells (IKC) | Shin Kong Wu Ho-Su Memorial Hospital, Ivy Life Sciences, Co., Ltd | Hepatocellular Carcinoma, Liver Cancer | 05/12 | | | |
| Active, not recruiting | 2/3 | 350 | Europe, Japan, US, RoW | Abemaciclib, LY2835219, Abiraterone Acetate, Prednisone, Placebo | Eli Lilly and Company | Prostate Cancer | 01/24 | 06/26 | | |
ACTRN12617000351314: The effect of Chinese herbal medicine on sleep quality in stressed people suffering from insomnia |
|
|
| Not yet recruiting | 2 | 20 | | | University of Technology Sydney, University of Technology Sydney | Insomnia, Stress | | | | |
MRG002-006, NCT04839510: A Study of MRG002 in the Treatment of HER2-positive Unresectable Locally Advanced or Metastatic Urothelium Cancer |
|
|
| Recruiting | 2 | 58 | RoW | MRG002 | Shanghai Miracogen Inc. | Locally Advanced Urothelial Cancer, Metastatic Urothelial Carcinoma | 06/22 | 09/22 | | |
NCT04426968: A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B |
|
|
| Completed | 2 | 96 | RoW | Hepalatide 2.1mg, L47, Hepalatide 4.2mg, Hepalatide 6.3mg, placebo 2.1mg, placebo 4.2mg, placebo 6.3mg, Pegylated Interferon, Pegasys | Shanghai HEP Pharmaceutical Co., Ltd. | Hepatitis B, Chronic | 11/23 | 11/23 | | |
NCT04492293: An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer |
|
|
| Recruiting | 2 | 115 | RoW | ICP-192 | Beijing InnoCare Pharma Tech Co., Ltd. | Bladder Urothelial Cancer | 12/24 | 06/25 | | |
NCT05763199: Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy |
|
|
| Recruiting | 2 | 20 | US | AHCC, A standardized extract of cultured Lentinula edodes mycelia, Chemotherapy, Placebo | University of California, Davis, Amino Up Chemicals Co., Ltd., National Cancer Institute (NCI) | Ovarian Epithelial Carcinoma, Fallopian Tube Carcinoma, Peritoneal Carcinoma | 04/26 | 07/27 | | |
NCT05405439: To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate Cancer |
|
|
| Terminated | 1/2 | 39 | RoW | TQB3823 tablets, Abiraterone acetate tablets, prednisone acetate tablets | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Metastatic Castration-resistant Prostate Cancer | 07/23 | 07/23 | | |
| Withdrawn | 1/2 | 75 | Europe, US | IMC-C103C, Atezolizumab, TECENTRIQ | Immunocore Ltd | Select Advanced Solid Tumors | 09/23 | 09/23 | | |
| Recruiting | 1/2 | 727 | Europe, Canada, US, RoW | Brenetafusp, Brenetafusp and pembrolizumab, Brenetafusp and chemotherapy, Brenetafusp and monoclonal antibodies and chemotherapy, Brenetafusp and tebentafusp, Brenetafusp and bevacizumab, Brenetafusp and kinase inhibitors | Immunocore Ltd | Select Advanced Solid Tumors | 02/26 | 08/26 | | |
|
NCT06452693: A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B |
|
|
| Not yet recruiting | 1/2 | 162 | RoW | TQA3038 injection/placebo, Nucleotide drugs Control group | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Hepatitis B, Chronic | 09/26 | 09/26 | | |
| Recruiting | 1/2 | 390 | US | ACR-368, prexasertib, Gemcitabine, OncoSignature | Acrivon Therapeutics, GOG Foundation | Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma | 07/26 | 12/27 | | |
NCT06186414: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC |
|
|
| Recruiting | 1 | 152 | RoW | SIM0237, SIM0237 and BCG | Jiangsu Simcere Pharmaceutical Co., Ltd., Shanghai Xianxiang Medical Technology Co., Ltd. | Non-Muscle-Invasive Bladder Cancer (NMIBC) | 01/27 | 12/30 | | |
NRG-GY022, NCT03997370: Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol |
|
|
| Recruiting | 1 | 350 | US | Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Iohexol, Omnipaque | NRG Oncology, National Cancer Institute (NCI) | Malignant Solid Neoplasm | 02/27 | 02/28 | | |
NCT05473624: Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors |
|
|
| Recruiting | 1 | 153 | RoW | HRS-1167 | Jiangsu HengRui Medicine Co., Ltd. | Advanced Solid Tumors | 12/24 | 12/24 | | |
NCT04953117: A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease |
|
|
| Recruiting | N/A | 286 | RoW | DCB of Lepu Medical(dimeter≥2.00 mm), Coronary Drug Coated Balloon Catheter of Lepu Medical for coronary small vessels, Restore DEB, RESTORE Paclitaxel releasing coronary balloon catheter, DCB of Lepu Medical(dimeter<2.00 mm), Coronary Drug Coated Balloon Catheter of Lepu Medical for coronary very small vessels | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease | 06/22 | 04/23 | | |
NCT05412147: The Effect of RECO-18 on Infertile Women Undergoing in Vitro Fertilization-embryo Transfer |
|
|
| Not yet recruiting | N/A | 80 | NA | RECO-18, Multi-vitamins | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Fertility Disorders, Infertility, Female | 04/23 | 04/23 | | |
NCT03463785: Does Race Make a Difference in Obstructive Sleep Apnea? |
|
|
| Completed | N/A | 58 | Europe, RoW | cone beam computed tomography, Mandibular advancement device (MAD) | Academic Centre for Dentistry in Amsterdam, Shandong University | Obstructive Sleep Apnea of Adult | 12/24 | 12/24 | | |
| Recruiting | N/A | 100 | RoW | Dopamine, Fractional Flow Reserve, Renal, Renal artery stenting | Peking University First Hospital | Renal Artery Stenosis Atherosclerotic, Secondary Hypertension Renal Arterial | 03/25 | 03/25 | | |
NCT03005444: Anticoagulation for Advanced Cirrhotic Patients After TIPS |
|
|
| Recruiting | N/A | 254 | RoW | Rivaroxaban, Nadroparin or Enoxaparin | Air Force Military Medical University, China | Liver Cirrhosis | 12/23 | 12/24 | | |
NCT06060158: Feasibility of Internet Group CBT-I for Gyn Oncology Patients |
|
|
| Completed | N/A | 5 | US | Cognitive Behavioral Therapy for Insomnia | University of California, Davis | Insomnia | 12/24 | 12/24 | | |
NCT04815668: Acupuncture at the Sphenopalatine Ganglion in the Treatment of Moderate-to-severe Seasonal Allergic Rhinitis |
|
|
| Recruiting | N/A | 120 | RoW | Acupuncture group, Placebo acupuncture group, Rescue medication group | Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Aerospace 731 Hospital | Seasonal Allergic Rhinitis | 05/24 | 08/24 | | |
| Active, not recruiting | N/A | 4009 | RoW | CYP2C19 genotype testing, clopidogrel, ticagrelor | Beijing Anzhen Hospital | Angina, Stable, Acute Coronary Syndrome, Drug-Eluting Stents, Genotype | 04/25 | 08/25 | | |
NCT05755776: The Efficacy and Safety of Tenofovir Amibufenamide to Treat Low-level Viraemia After Entecavir Treatment |
|
|
| Recruiting | N/A | 204 | RoW | TMF, Heng Mu | The Second Affiliated Hospital of Chongqing Medical University, Jiangsu Hansoh Pharmaceutical Co., Ltd. | Chronic Hepatitis B | 12/24 | 12/24 | | |
| Not yet recruiting | N/A | 796 | RoW | hydroxychloroquine and levothyroxine, Levothyroxine | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Recurrent Pregnancy Loss, Euthyroid With Thyroid Antibodies | 03/35 | 03/37 | | |
NCT06005727: Cryotherapy Post-haemorrhoidectomy (CYPHER) Randomized Controlled Trial |
|
|
| Recruiting | N/A | 50 | RoW | Transanal ice pack | Singapore General Hospital | Hemorrhoids, Postoperative Pain, Postoperative Complications, Cryotherapy Effect | 12/24 | 12/24 | | |
NCT06459427: Robot-Assisted Minimally Invasive Surgery for Brainstem Hemorrhage |
|
|
| Not yet recruiting | N/A | 110 | RoW | Robot-Assisted Stereotactic Brainstem Hematoma Puncture, "Remebot" Neurosurgical Robot, Conservative non-surgical treatment, Medical therapy | Yanbing Yu | Brain Stem Hemorrhage, Robotic Surgical Procedures, Stereotactic Techniques | 12/27 | 12/27 | | |
SOROCk, NCT04251052: A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer |
|
|
| Recruiting | N/A | 2262 | Canada, US, RoW | Bilateral Salpingectomy, Bilateral Salpingectomy with Oophorectomy, bilateral salpingo-oophorectomy, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Transvaginal Ultrasound, transvaginal sonography, TVS, TVU, Ultrasound Imaging, 2-Dimensional Grayscale Ultrasound Imaging, 2-Dimensional Ultrasound Imaging, 2D-US, Ultrasonography, Ultrasound, Ultrasound Test, Ultrasound, Medical, US | NRG Oncology, National Cancer Institute (NCI) | Ovarian Carcinoma | 06/36 | 06/37 | | |
| Cai, Hanqing |
| Completed | 3 | 533 | RoW | Chiglitazar 32mg, Bilessglu, CS038, Chiglitazar 48mg, Placebo, Chiglitazar simulator, Metformin Hydrochloride, Glucophage | Chipscreen Biosciences, Ltd. | Type 2 Diabetes | 02/23 | 02/23 | | |
NCT05102149: Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus |
|
|
| Recruiting | 3 | 672 | RoW | PB-201, Vildagliptin, PB-201 matched placebo, Vildagliptin matched placebo | PegBio Co., Ltd. | Type 2 Diabetes Mellitus (T2DM) | 11/23 | 04/25 | | |
NCT06350890: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes |
|
|
| Active, not recruiting | 3 | 408 | RoW | HTD1801, berberine ursodeoxycholate, Placebo | HighTide Biopharma Pty Ltd | T2DM (Type 2 Diabetes Mellitus) | 03/25 | 09/25 | | |
Symphony2, NCT06353347: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin |
|
|
| Active, not recruiting | 3 | 551 | RoW | HTD1801, berberine ursodeoxycholate, Placebo | HighTide Biopharma Pty Ltd | Type 2 Diabetes Mellitus | 03/25 | 12/25 | | |
NCT06738979: A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects |
|
|
| Not yet recruiting | 3 | 408 | RoW | TQF3510 (Semaglutide Injection), Wegovy® | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Obesity | 07/26 | 08/26 | | |
NCT05278338: Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosis |
|
|
| Recruiting | 2 | 200 | RoW | JMT103, Denosumab, Placebo | Shanghai JMT-Bio Inc. | Postmenopausal Osteoporosis | 12/23 | 03/24 | | |
NCT06481085: To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus |
|
|
| Not yet recruiting | 2 | 318 | RoW | HDM1002 50 mg, HDM1002, HDM1002 100 mg, HDM1002 200 mg, HDM1002 400 mg, HDM1002 200 mg BID, Placebo, Matching placebo for group A to group E | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Type 2 Diabetes | 04/25 | 04/25 | | |
NCT06606483: A Study to Evaluate the Efficacy and Safety of MDR-001 in Subjects Who Are Obesity or Overweight |
|
|
| Not yet recruiting | 2 | 300 | RoW | MDR-001, Placebo | MindRank AI Ltd | Obesity, Overweight and Obesity | 07/25 | 09/25 | | |
NCT06606509: The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM). |
|
|
| Not yet recruiting | N/A | 1000 | RoW | Continuous Glucose Monitoring System (GX-01S) | Nanjing First Hospital, Nanjing Medical University | Type1 Diabetes Mellitus | 10/26 | 06/27 | | |
